Of note, the risk of oligohydramnios was more than 2-fold higher with COX-2 selective inhibitors versus unexposed pregnancies (PS-adjusted RR, 2.64 [95% CI, 1.47 to 4.75]) (Fig 3). Here, PTGS2 is linked to oligohydramnios.